Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.200
-0.050 (-2.22%)
At close: Apr 28, 2026, 4:00 PM EDT
2.160
-0.040 (-1.82%)
After-hours: Apr 28, 2026, 4:47 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $396.13 million as of April 28, 2026. Its market cap has increased by 1,028.91% in one year.
Market Cap
396.13M
Enterprise Value
322.58M
1-Year Change
1,028.91%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $396.13M, a decrease of -62.31%. That is a compound annual growth rate of -18.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 405.13M | 366.42% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 412.89M |
| Neumora Therapeutics | 411.05M |
| Vanda Pharmaceuticals | 407.25M |
| vTv Therapeutics | 406.54M |
| PureTech Health | 402.93M |
| Niagen Bioscience | 395.62M |
| Immuneering | 390.77M |
| Enanta Pharmaceuticals | 386.25M |